Alpha 2.0
Login Register
» Authors » A Y L Lau

A Y L Lau

Explore the profile of A Y L Lau including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 9
Followers 0
Related Specialty
General Medicine
Top 10 Co-Authors
D Y W Siu
L K S Wong
V C T Mok
A Y Y Chan
E H C Wong
V Mok
S H S Lo
V W Y Lee
H Leung
S Y Fan
Published In
Hong Kong Med J
Affiliations
Soon will be listed here.
Recent Articles
1.
Neurocognitive impairment after intensity-modulated radiotherapy in patients with nasopharyngeal cancer: association with radiation dose and retinal vascular characteristics (abridged secondary publication)
Chow J, Zee B, Lau A, Au K, Lau A
Hong Kong Med J . 2025 Jan; 30 Suppl 7(6):33-36. PMID: 39743975
No abstract available.
2.
Virtual multidisciplinary stroke care clinic for community-dwelling stroke survivors: a randomised controlled trial (abridged secondary publication)
Chau J, Lo S, Lau A, Lee V, Choi K, Shum E, et al.
Hong Kong Med J . 2024 Jul; 30 Suppl 3(3):32-33. PMID: 38962922
No abstract available.
3.
Neutralising antibodies to interferon-beta therapy in relapsing multiple sclerosis: a pilot study
Lau A, Chan E, Lau K, Mok V, Siu D, Lee R
Hong Kong Med J . 2019 Aug; 25 Suppl 5(4):22-25. PMID: 31416982
No abstract available.
4.
Effects of collateral circulation on haemodynamic flow status in intracranial artery stenosis depicted by computational fluid dynamics
Leung T, Fan S, Ip H, Lau A, Siu D, Dai E, et al.
Hong Kong Med J . 2019 Aug; 25 Suppl 5(4):18-21. PMID: 31416981
No abstract available.
5.
Refractory bulbar and respiratory dysfunction in a young Chinese woman with seronegative, muscle-specific tyrosine kinase antibody-positive myasthenia gravis: response to cyclophosphamide and rituximab treatment
Lau A, Chan A, Mok V
Hong Kong Med J . 2011 Feb; 17(1):77-9. PMID: 21282832
The use of cyclophosphamide and rituximab for patients with refractory myasthenia gravis has shown promising results. We report on a 31-year-old Chinese woman with acetylcholine receptor antibody-negative and muscle-specific tyrosine...
6.
An expedited stroke triage pathway: the key to shortening the door-to-needle time in delivery of thrombolysis
Lau A, Soo Y, Graham C, Woo W, Wong E, Leung H, et al.
Hong Kong Med J . 2010 Dec; 16(6):455-62. PMID: 21135422
Objectives: To assess time management of stroke thrombolysis triage and functional outcomes in patients receiving recombinant tissue plasminogen activator for hyperacute stroke, and identify bottlenecks in delivery of the treatment....